|
Decades of experience, strong patient support, and more.
|
|
|
|
|
|
NovoSeven®
RT is used to treat bleeding episodes in people
with hemophilia A or B with inhibitors,
congenital Factor VII deficiency, Glanzmann’s
thrombasthenia with resistance to platelets, and
acquired hemophilia.
|
|
|
|
|
Trusted for over 30 years
|
|
NovoSeven®
RT was the first recombinant factor VIIa (rFVIIa) therapy
approved for hemophilia A and B with inhibitors, and it’s
the only rFVIIa treatment approved for all
ages—children, adolescents, and adults.
|
|
|
|
|
Bob, Chase and Sid live
with hemophilia A with inhibitors.
Miguel lives with hemophilia B with
inhibitors.
|
|
Scroll to learn whether NovoSeven®
RT is right for you.
|
|
|
|
Selected Important Safety Information
|
|
What is the most important information I should
know about NovoSeven® RT?
|
|
NovoSeven® RT may cause serious side effects,
including:
|
| |
•
|
Serious blood clots that form
in veins and arteries with the use
of NovoSeven® RT have been reported
|
|
| |
•
|
Your healthcare provider should
discuss the risks and explain the
signs and symptoms of blood clots to
you. Some signs of a blood clot may
include pain, swelling, warmth,
redness, or a lump in your legs or
arms, chest pain, shortness of
breath, or sudden severe headache
and/or loss of consciousness or
function
|
|
| |
•
|
Your healthcare provider should
monitor you for blood clots during
treatment with NovoSeven® RT
|
|
| Please click here or scroll below for additional Important Safety Information. |
|
|
|
|
Important “factors” you should know about
|
|
NovoSeven®
RT offers fast bleed control for even the most
life-threatening bleedsa—it’s 90% effective in all severe bleeding
episodes.b
And, it has a
proven safety profile for use before, during, and after
surgery.
|
|
|
aIn
compassionate use situations including surgery, central
nervous system hemorrhages, severe intra-abdominal bleeding,
and other life-threatening bleeding episodes.
bFor
hemophilia patients with inhibitors. Data shown from
compassionate use program and 2 clinical studies.
|
|
|
|
Dosing designed
with you in mind
|
|
NovoSeven®
RT is available in 4 vial sizes, more than any other rFVIIa
therapy, so you might need fewer vials to infuse your dose.
And, you can infuse quickly, in 2-5 minutes.c
|
|
|
|
cAdminister as a slow bolus injection over 2-5 minutes,
depending on the dose administered.
|
|
|
|
|
Get support when you need it
|
|
We offer comprehensive, personalized support so
you can focus on enjoying your life. With
NovoCare®, you’ll receive:
|
-
One-on-one access to a NovoCare®
Specialist
-
Financial product assistance
- Educational resources
|
|
|
|
|
|
|
What is NovoSeven® RT?
|
|
NovoSeven® RT (coagulation Factor VIIa, recombinant) is an
injectable medicine used for:
|
| |
•
|
Treatment of bleeding and prevention of bleeding
for surgeries and procedures in adults and
children with hemophilia A or B with inhibitors,
congenital Factor VII (FVII) deficiency, and
Glanzmann’s thrombasthenia with a decreased or
absent response to platelet transfusions
|
|
| |
•
|
Treatment of bleeding and prevention of bleeding
for surgeries and procedures in adults with
acquired hemophilia
|
|
|
Important Safety Information (cont’d)
|
| |
•
|
You should not use NovoSeven® RT if you have ever had allergic
(hypersensitivity) reactions, including severe,
whole body reactions (anaphylaxis) to
NovoSeven® RT, any of its ingredients, or mice,
hamsters, or cows. Signs of allergic reaction
include shortness of breath, rash, itching
(pruritus), redness of the skin (erythema), or
fainting/dizziness
|
|
|
What should I tell my healthcare provider before using
NovoSeven® RT?
|
| |
•
|
Tell your healthcare provider if you have any of
the following, as these may increase your risk
of blood clots:
|
| |
|
| |
◦
|
congenital hemophilia and are also
receiving treatment with aPCCs
(activated prothrombin complex
concentrates)
|
| |
◦
|
are an older patient particularly
with acquired hemophilia and
receiving other agents to stop
bleeding
|
| |
◦
|
history of heart or blood vessel
diseases
|
|
| |
•
|
Tell your healthcare provider and pharmacist
about all the medicines you take, including all
prescription and non-prescription medicines,
such as over-the-counter medicines, supplements,
or herbal remedies
|
|
|
What are the possible side effects of NovoSeven® RT?
|
| |
•
|
The most common and serious side effects are
blood clots
|
|
| |
•
|
Tell your healthcare provider about any side
effects that bother you or do not go away, and
seek medical help right away if you have signs
of a blood clot or allergic reaction
|
|
| Please click here for Prescribing Information. |
|
NovoSeven®
RT is a prescription medication.
|
| You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. |
|
|
|
PLEASE DO NOT RESPOND TO THIS EMAIL. If you would like to contact us, please click here or call 1‑877‑744‑2579.
|
|
NovoSeven® is a registered trademark of Novo Nordisk Health Care AG.
NovoCare® is a registered trademark of Novo Nordisk A/S.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
© 2020 Novo Nordisk All rights reserved.
US20NSVN00137
November 2020
|
|
|
|
|